Literature DB >> 16084311

Saccharomyces boulardii: basic science and clinical applications in gastroenterology.

Jean-Paul Buts1, Paul Bernasconi.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16084311     DOI: 10.1016/j.gtc.2005.05.009

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


× No keyword cloud information.
  6 in total

1.  Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.

Authors:  Lucie Etienne-Mesmin; Valérie Livrelli; Maud Privat; Sylvain Denis; Jean-Michel Cardot; Monique Alric; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

Review 2.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

3.  Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.

Authors:  Sandrine Graff; Sajjad Hussain; Jean-Claude Chaumeil; Christine Charrueau
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children.

Authors:  Jan Józefczuk; Bogdan Marian Woźniewicz
Journal:  ISRN Gastroenterol       Date:  2011-07-06

5.  Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.

Authors:  Keya Rani Lahiri; Raghvendra Singh; Mohini Apte; Mahantesh Patil; Amar Taksande; Rafael Varona; Godhuli Chatterjee; Manish Verma; Sandrine Brette; Marcos Iii Perez
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-04-10

6.  Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications.

Authors:  Rima Hatoum; Steve Labrie; Ismail Fliss
Journal:  Front Microbiol       Date:  2012-12-19       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.